v3.25.2
REVENUES (Tables)
6 Months Ended
Jun. 30, 2025
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue [Table Text Block]
The Company’s Revenues by segment and by payers/customer groups were as follows:
Three Months Ended June 30, 2025Three Months Ended June 30, 2024
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Payer/Customer
Dx
   Clients24 %— %— %24 %24 %— %— %24 %
   Patients10 %— %— %10 %10 %— %— %10 %
   Medicare and Medicaid%— %— %%%— %— %%
   Third party36 %— %— %36 %36 %— %— %36 %
Total Dx revenues by payer78 %— %— %78 %78 %— %— %78 %
BLS
Pharmaceutical, biotechnology, and medical device companies%%%22 %%%%22 %
Total Revenues
87 %%%100 %87 %%%100 %
Six Months Ended June 30, 2025Six Months Ended June 30, 2024
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Payer/Customer
Dx
   Clients24 %— %— %24 %24 %— %— %24 %
   Patients10 %— %— %10 %10 %— %— %10 %
   Medicare and Medicaid%— %— %%%— %— %%
   Third party36 %— %— %36 %36 %— %— %36 %
Total Dx revenues by payer78 %— %— %78 %78 %— %— %78 %
BLS
Pharmaceutical, biotechnology, and medical device companies%%%22 %%%%22 %
Total Revenues87 %%%100 %87 %%%100 %
Contract with Customer, Asset and Liability [Table Text Block]
The following table provides information about accounts receivable, unbilled services, and unearned revenue from contracts with customers:
June 30, 2025December 31, 2024
Dx accounts receivable$1,410.6 $1,259.3 
BLS accounts receivable750.1 729.5 
Less: BLS allowance for credit losses(40.1)(44.7)
Accounts receivable, net$2,120.6 $1,944.1 
Gross unbilled services$162.0 $160.5 
Less: reserve for unbilled services(5.9)(7.6)
Unbilled services$156.1 $152.9 
Financing Receivable, Allowance for Credit Loss [Table Text Block] The rollforward for the allowance for credit losses was as follows:
Accounts ReceivableUnbilled ServicesTotal
Allowance for credit losses at December 31, 2024$44.7 $7.6 $52.3 
Credit loss expense2.52.5 
Write offs(9.1)(2.1)(11.2)
Foreign currency impact
2.0 0.4 2.4 
Allowance for credit losses at June 30, 2025$40.1 $5.9 $46.0